Meet Genmab: International biotechnology

About the company

Genmab is an international biotechnology company specialising in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

A perfect match: Utrecht Region matches Genmab’s key site selection drivers

  • Access to Utrecht’s strong life sciences and health ecosystem helps strengthen the company’s R&D capabilities
  • The availability of a highly educated workforce and the ability to attract and retain key talent is extremely important to the company

Jan van de Winkel, CEO Genmab: "An outstanding biotech hub"

“Utrecht is an excellent location for biotech companies that want to establish their business. The region provides an exceptional innovation ecosystem thanks to the combination of a highly educated workforce, a world-class university, outstanding hospitals and renowned life sciences research institutes. Utrecht is centrally located in the Netherlands and provides an inspirational environment to work, live and relax in.”​

    Visit the website